verapamil has been researched along with losartan potassium in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Jelkmann, W; Pagel, H; Weiss, C | 1 |
Brookins, J; Fisher, JW; McGonigle, RJ; Pegram, BL | 1 |
Barrientos, A; Borque, M; González-Mate, A; Herrero, JA; Marcello, M; Torralbo, A; Trobo, JI; Velasco, E | 1 |
Bordon, P; Foresta, C; Gottardello, F; Mioni, R; Nogara, A; Rossato, M | 1 |
Allegra, A; Aloisi, C; Baldari, S; Buemi, M; Imbesi, D; Laganà, A; Morabito, N; Palella, S; Privitera, M; Villari, C | 1 |
Bäcker, A; Fandrey, J; Jelkmann, W; Kramer, HJ; Meyer-Lehnert, H; Vogel, V | 1 |
1 trial(s) available for verapamil and losartan potassium
Article | Year |
---|---|
Is erythropoietin-induced hypertension a phenomenon due to the intracellular Ca++ mobilisation?
Topics: Adult; Blood Circulation; Calcium; Erythropoietin; Gallopamil; Humans; Ketanserin; Male; Nifedipine; Recombinant Proteins; Vasoconstrictor Agents; Verapamil | 1994 |
6 other study(ies) available for verapamil and losartan potassium
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Erythropoietin and blood pressure.
Topics: Angiotensin II; Animals; Blood Pressure; Erythropoietin; Kidney; Male; Perfusion; Rats; Rats, Inbred Strains; Recombinant Proteins; Verapamil | 1989 |
Enhanced erythropoietin production by calcium entry blockers in rats exposed to hypoxia.
Topics: Animals; Biological Assay; Blood Pressure; Calcium Channel Blockers; Erythropoietin; Female; Hypoxia; Male; Mice; Polycythemia; Rats; Rats, Inbred Strains; Time Factors; Verapamil | 1987 |
Alterations in renal endothelin production in rats with reduced renal mass.
Topics: Animals; Enalapril; Endothelins; Erythropoietin; Hypertension, Renal; Kidney; Kidney Diseases; Male; Nephrectomy; Radioimmunoassay; Rats; Rats, Wistar; Recombinant Proteins; Verapamil | 1995 |
Erythropoietin and testicular steroidogenesis: the role of second messengers.
Topics: Alkaloids; Animals; Calcium; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Erythropoietin; Leydig Cells; Male; Protein Kinase C; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Second Messenger Systems; Staurosporine; Testis; Testosterone; Verapamil | 1995 |
Effects of erythropoietin on endothelin-1 synthesis and the cellular calcium messenger system in vascular endothelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Calcimycin; Calcium; Calcium Channel Blockers; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Erythropoietin; Gallic Acid; Genistein; Ionophores; Isoflavones; Muscle, Smooth, Vascular; Protein Kinase C; Receptor Protein-Tyrosine Kinases; Recombinant Proteins; Second Messenger Systems; Swine; Verapamil | 1997 |